Samsung Bioepis is tightening its grip on the U.S. biosimilar market with FDA approval to sell an unbranded version of ...

The National Assembly criticized the Ministry of Health and Welfare after the latter revised the outlay for the second ...

BeOne Medicines Korea, the newly rebranded Korean subsidiary of global oncology company BeOne Medicines (formerly BeiGene), ...

Yonsei University College of Medicine and the KAIST Graduate School of Medical Science and Engineering (GSMSE) signed a ...

GCCL (Global Clinical Central Lab) said Thursday it established an assay for monoamine oxidase B (MAO-B), a central nervous ...

"Doctor, my hair is suddenly falling out. Didn't you say this anti-cancer drug wouldn't cause hair loss?"Ms. Jang, a ...

TiumBio announced Wednesday that it will present clinical trial results for merigolix (TU2670), a drug in development for the ...

Novelty Nobility said Thursday it has voluntarily withdrawn its preliminary listing review application for Kosdaq.In July last year, the company received an A grade from two specialized rating agencie ...

Vaxcellbio said it secured a new government-funded R&D project worth 8.6 billion won ($6.3 million) under the Ministry of ...

Lixiana’s (edoxaban) patent clock is now ticking loud enough for every generics player in Korea to hear.Last Friday, Korean ...

Professor Yoon Jin-a of the Department of Rehabilitation Medicine at Pusan National University Hospital (PNUH) will receive 6 ...

Gachon University Gil Medical Center invited five Mongolian children with congenital heart disease to undergo free surgery.